Xeris to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Summary

Xeris Biopharma Holdings (Nasdaq: XERS) announced its participation in the Jefferies Global Healthcare Conference. Senior management will host a fireside chat on June 6 at 2:00 PM Eastern Time. A live webcast will be available on Xeris’ Investor Relations website and will remain accessible for 60 days.

Positive

• Participation in a prestigious conference like Jefferies Global Healthcare Conference enhances visibility.
• Opportunity for senior management to directly engage with investors and analysts.

Negative

• No new product announcements or financial updates were provided in the PR.
• information on how this participation will concretely benefit the company's financials.

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6 at 2:00pm Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Xeris’ Investor Relations website at https://xerispharma.com/investor-relations or https://wsw.com/webcast/jeff302/xers/1871136. A replay of the webcast will be available for 60 days.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing differentiated and innovative products across a range of therapies. Xeris has three commercially available products: Gvoke^®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis^®, a proven therapy for primary periodic paralysis; and Recorlev^® for the treatment of endogenous Cushing’s syndrome. Xeris has a pipeline of development and partnered programs using its formulation sciences, XeriSol^™ and XeriJect^®, to support long-term product development and commercial success.

Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow Xeris on X, LinkedIn or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240530275222/en/

Investor Contact

Allison Wey

Senior Vice President, Investor Relations and Corporate Communications

awey@xerispharma.com

Source: Xeris Biopharma Holdings, Inc.

FAQ

When is Xeris Biopharma Holdings participating in the Jefferies Global Healthcare Conference?

Xeris Biopharma Holdings will participate on June 6 at 2:00 PM Eastern Time.

What is the stock symbol for Xeris Biopharma Holdings?

The stock symbol for Xeris Biopharma Holdings is XERS.

Where can I watch the Xeris fireside chat at the Jefferies Global Healthcare Conference?

The fireside chat can be watched live on the Investor Relations section of the Xeris website or via the provided webcast link.

How long will the webcast replay be available?

The webcast replay will be available for 60 days.